Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL (NCT04215809)

🔬

Loading study...

Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL (NCT04215809) | TrialReferrals